所有图片(1)
About This Item
线性分子式:
HSCH2CH2CH2SO3Na
CAS号:
分子量:
178.21
Beilstein:
5362242
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22
推荐产品
一般描述
3-巯基-1-丙磺酸钠通过化学吸附在镀金基质上形成自组装单层。
应用
3-巯基-1-丙磺酸钠(MPS)可通过硫醇-烯反应与四乙烯基硅烷发生光化学反应，从而制备四取代有机硅硫醚。它还可以用作封端剂官能化金纳米粒子，有望用于放射治疗和药物递送领域应用。
MPS还可用于通过液相还原氯化铑 (III)制备Rh纳米粒子。
MPS还可用于通过液相还原氯化铑 (III)制备Rh纳米粒子。
警示用语：
Warning
危险声明
危险分类
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 1
闪点(°F)
159.8 °F - closed cup
闪点(°C)
71 °C - closed cup
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
Nucleobases functionalized quantum dots and gold nanoparticles bioconjugates as a fluorescence resonance energy transfer (FRET) system-Synthesis, characterization and potential applications
Rodzik-Czalka L, et al.
Journal of Colloid and Interface Science, 514(20), 479-490 (2018)
Mieke Aldenhoven et al.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21(6), 1106-1109 (2015-02-25)
Allogeneic hematopoietic cell transplantation (HCT) is the only treatment able to prevent progressive neurodegenerative disease in a selected group of mucopolysaccharidosis (MPS) disorders. However, its use was historically limited by the high risk of graft failure and transplantation-related morbidity and
Naoyuki Sakamoto et al.
Nanoscale, 1(1), 106-109 (2010-07-21)
Highly dispersed rhodium nanoparticles (1.7 +/- 0.3 nm) prepared by a liquid-phase reduction method were loaded on a solid solution of GaN and ZnO without forming aggregates, achieving improved activity for visible-light-driven overall water splitting when the nanoparticles are coated
Highly dispersed noble-metal/chromia (core/shell) nanoparticles as efficient hydrogen evolution promoters for photocatalytic overall water splitting under visible light
Sakamoto N, et al.
Nanoscale, 1(1), 106-109 (2009)
J Tie et al.
Annals of oncology : official journal of the European Society for Medical Oncology, 26(8), 1715-1722 (2015-04-09)
Early indicators of treatment response in metastatic colorectal cancer (mCRC) could conceivably be used to optimize treatment. We explored early changes in circulating tumor DNA (ctDNA) levels as a marker of therapeutic efficacy. This prospective study involved 53 mCRC patients
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门